Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
r-Hu-EPO vs Transfusion vs Polyvitamins in Anemic Cancer Patients
NCT00180999Phase 3Terminated
- Sponsor
- Gustave Roussy
- Start
- Feb 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of erythropoietin in anemia and fatigue (3 arms), sponsored by Gustave Roussy. Primary endpoint: Quality of life, in particular when related to tiredness (FACT F). Started Feb 2002; status: terminated.
02
Drugs
erythropoietin
03
Conditions
anemiafatigue
Beyond the preview
Go deeper on NCT00180999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180999.